Fred Schwarzer is the Chief Executive Officer of IGM Biosciences, a clinical-stage biotechnology company.
Fred Schwarzer is the Chief Executive Officer of IGM Biosciences, a clinical-stage biotechnology company. He leads the company's strategic direction in developing Immunoglobulin M (IgM) antibodies for cancer and autoimmune diseases, and pharmaceutical preparations for inflammatory and immune-related conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library